Compound Detail
CHEMBL419667
RELCOVAPTAN 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
COc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3[C@](O)(c3ccccc3Cl)[C@@H]2C(=O)N2CCC[C@H]2C(N)=O)cc1OC
Basic Information
| ChEMBL ID | CHEMBL419667 |
| Name | RELCOVAPTAN |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | CEBYCSRFKCEUSW-NAYZPBBASA-N |
5
Targets
14
Activities
3
Assay Types
0
PK Parameters
20
Publications
6
Known Names
2
Mechanisms
Molecular Properties
620.5
MW (Da)
3.30
ALogP
7
HBA
2
HBD
139.5
PSA (Ų)
0.41
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Vasopressin V1a receptor antagonist | ANTAGONIST | Vasopressin V1a receptor | ✓ | ✓ |
| Oxytocin receptor antagonist | ANTAGONIST | Oxytocin receptor | ✓ | ✓ |
Activity Summary
Ki 12 meas. best 9.72
EC50 1 meas. best 5.32
IC50 1 meas. best 7.89
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vasopressin V1a receptor CHEMBL1889 | Ki | 9.72 | 9.1511 | 0.2 | 9 |
| Vasopressin V1a receptor CHEMBL2868 | Ki | 8.85 | 8.85 | 1.4 | 1 |
| Vasopressin V1a receptor CHEMBL1889 | IC50 | 7.89 | 7.89 | 13.0 | 1 |
| Vasopressin V2 receptor CHEMBL1790 | Ki | 6.75 | 6.75 | 178.0 | 1 |
| Vasopressin V2 receptor CHEMBL3766 | Ki | 6.54 | 6.54 | 285.0 | 1 |
| Free fatty acid receptor 4 CHEMBL5339 | EC50 | 5.32 | 5.32 | 4775.2 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5724696 | U2OS | 24 |
| - | 10.6019/CHEMBL5724696 | TERT-RPE1 | 24 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 10 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 10 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 8 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 8 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 8 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 8 |
| - | 10.6019/CHEMBL4689842 | U2OS | 8 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 8 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 8 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 8 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 8 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 8 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 8 |
| 17850055 | 10.1021/jm061404q | Vasopressin V1a receptor | 5 |
| 12036368 | 10.1021/jm010544r | Vasopressin V2 receptor | 3 |
| 23075044 | 10.1021/jm301182j | Homo sapiens | 2 |
Data from ChEMBL 36 via Core Engine